Pharmagest Interactive SA
F:PHF
Intrinsic Value
Pharmagest Interactive SA engages in the development of management software packages for drugstores. [ Read More ]
The intrinsic value of one
PHF
stock under the Base Case scenario is
66.34
EUR.
Compared to the current market price of 55.4 EUR,
Pharmagest Interactive SA
is
Undervalued by 16%.
Pharmagest Interactive SA's market capitalization is 832.7m EUR.
PHF stock price is 55.4 EUR.
PHF stock price (55.4 EUR) is 16% less than its Intrinsic Value (66.34 EUR).
PHF has upside potential of 56% compared to the average analyst price target.
Open Wall St Estimates
PHF's ROIC (Return on Invested Capital) has decreased in the last 3 years from 16% to 16%.
PHF's ROE (Return on Equity) has increased in the last 3 years from 23% to 23%.
PHF's Revenue has grown by 3% over the past 12 months.
PHF's ROIC (Return on Invested Capital) for the past 12 months is positive and is equal to 16%.
PHF's Revenue is forecast to grow at a rate of 7% per year over the next 3 years.
PHF's short-term assets (132m EUR) exceed its short-term liabilties (108m EUR).
PHF's Revenue has been growing by 9% per year for the last 3 years.
PHF's ROE (Return on Equity) for the past 12 months is positive and is equal to 23%.
PHF has positive Net Income for the last twelve months.
PHF has positive three-year average ROIC (Return on Invested Capital): 17%. The company is efficient at using invested capital to generate operating income.
PHF has negative Net Debt. This means that the company has more cash and short-term investments (55m EUR) than debt (45m EUR).
PHF has positive Operating Income for the last twelve months.
PHF has very high three-year average ROE (Return on Equity): 26%. The company is very efficient at transforming stockholders' equity into net income.
PHF's long-term assets (394m EUR) exceed its long-term liabilties (175m EUR).
PHF has positive Free Cash Flow for the last twelve months.
PHF has positive Gross Profit for the last twelve months.
PHF's D/E (Debt to Equity) is very low and is equal to 0.2.
PHF's Altman Z-Score is very high and is equal to 4.42.
Valuation Backtest
Pharmagest Interactive SA
Run backtest to discover the historical profit from buying and selling
PHF
stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Pharmagest Interactive SA
Balance Sheet Decomposition
Pharmagest Interactive SA
| Current Assets | 132.3m |
| Cash & Short-Term Investments | 54.7m |
| Receivables | 67.3m |
| Other Current Assets | 10.3m |
| Non-Current Assets | 261.8m |
| Long-Term Investments | 95.1m |
| PP&E | 32.9m |
| Intangibles | 130.3m |
| Other Non-Current Assets | 3.5m |
| Current Liabilities | 108.1m |
| Accounts Payable | 16.1m |
| Other Current Liabilities | 92m |
| Non-Current Liabilities | 66.6m |
| Long-Term Debt | 44.7m |
| Other Non-Current Liabilities | 22m |
Earnings Waterfall
Pharmagest Interactive SA
|
Revenue
|
219.8m
EUR
|
|
Cost of Revenue
|
-69.1m
EUR
|
|
Gross Profit
|
150.6m
EUR
|
|
Operating Expenses
|
-95.4m
EUR
|
|
Operating Income
|
55.2m
EUR
|
|
Other Expenses
|
-8.2m
EUR
|
|
Net Income
|
47m
EUR
|
Free Cash Flow Analysis
Pharmagest Interactive SA
PHF Profitability Score
Profitability Due Diligence
Pharmagest Interactive SA's profitability score is 66/100. The higher the profitability score, the more profitable the company is.
Score
Pharmagest Interactive SA's profitability score is 66/100. The higher the profitability score, the more profitable the company is.
PHF Solvency Score
Solvency Due Diligence
Pharmagest Interactive SA's solvency score is 68/100. The higher the solvency score, the more solvent the company is.
Score
Pharmagest Interactive SA's solvency score is 68/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
PHF Price Targets Summary
Pharmagest Interactive SA
According to Wall Street analysts, the average 1-year price target for
PHF
is 86.58 EUR
with a low forecast of 74.19 EUR and a high forecast of 107.98 EUR.
Shareholder Return
PHF Price
Pharmagest Interactive SA
| Average Annual Return | 15.15% |
| Standard Deviation of Annual Returns | 48.56% |
| Max Drawdown | -62% |
| Market Capitalization | 832.7m EUR |
| Shares Outstanding | 15 033 300 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Pharmagest Interactive SA
Country
Industry
Market Cap
Dividend Yield
Description
Pharmagest Interactive SA engages in the development of management software packages for drugstores. The company is headquartered in Villers-Les-Nancy, Grand Est. The company went IPO on 2000-10-20. The firm is engaged in the computerization of pharmaceutical dispensaries. Its flagship product is Integrated Portal Management Software, which provides pharmacists with permanent and immediate access to a range of online services and is used for the distribution of information and promotions for pharmaceutical suppliers and for pharmaceutical laboratories. In addition, the Company is engaged in the provision of maintenance services, technologies to manage medication compliance, as well as e-business solutions. The company operates through Noviatek, Sailendra, Multimeds, British Caremeds and Axigate, among others.
Contact
IPO
Employees
Officers
The intrinsic value of one
PHF
stock under the Base Case scenario is
66.34
EUR.
Compared to the current market price of 55.4 EUR,
Pharmagest Interactive SA
is
Undervalued by 16%.
You don't have any saved screeners yet
